Gait analysis is proving to be a vital tool in elderly health care, offering insights into overall health, frailty status and early signs of disease processes. With the help of novel technology, we’re now able to capture gait and mobility beyond mere observational analysis.
Hospital at Home models are expanding capacity for overcrowded hospitals and emergency departments and providing comfort to a growing range of patients. Dave Kerwar, co-founder of Inbound Health, discusses the best candidates for hospital at home care and opportunities for MedTech providers to enhance this model of care, as payers and CMS look at long-term adoption.
Chris Fourment, MD, Senior Vice President, Clinical Strategy at Iterative Health, who specializes in structuring clinical trial programs, discusses the new FDA guidance on decentralized clinical trials, and how DCTs can help spur health and research equity.
This week Huma Therapeutics received FDA Class II 510(k) clearance for its Software as a Medical Device (SaMD) platform, potentially speeding approval of a variety of AI and machine-learning (ML)-powered digital health devices. We spoke with Kaushik Gune, U.S. Head of Healthcare at Huma, about the current state of digital health technologies, the value of partnerships to enhance the use of real world data and how digital health is likely to advance in the coming years.
An adhesive developer explains why skin is so challenging to adhere to, why it’s never too early to explore skin-adhesive options for your wearable device, and recent milestones in stick-to-skin adhesive longevity.
Smart hospitals are revolutionizing health care with the help of AI, IoT and robotics. Following are the latest technology and data analytics tools and trends that are helping these hospitals of the future provide safer, more personalized care.
Connected devices already enable remote patient monitoring by collecting real-time data, such as injection date and time. With time, these benefits are likely to grow. Following are three areas where manufacturers are exploring new uses of digitalization in drug delivery to better understand the needs of patients and healthcare professionals and create more effective devices.
New data presented at the Technology and Heart Failure Therapeutics (THT) Conference showed that hemodynamic monitoring can slow the progression of heart failure in patients with reduced ejection fraction.
“The solution provider that builds the device and creates the algorithm should consider integration and accountability among multiple other challenges. But meeting the needs of the third element in the equation, the doctors, is key.”
The Intricon Biosensor CoE team has expertise in high-density microelectronics, miniaturization, ultra-low power, miniature molding, firmware development, and wireless communication.